Bloodless Cancer Treatment Results of Patients Who Do Not Want Blood Transfusion: Single Center Experience of 77 Cases

Autor: Suee Lee, Sung Yong Oh, Dong Mee Lee, Kyu-Yeol Lee, Kyeong Hee Kim, Jong-Hwan Lee, Sung Hyun Kim, Hyo-Jin Kim, Joo In Park, Jin-Yeong Han, H. Kwon
Rok vydání: 2008
Předmět:
Zdroj: Blood. 112:4068-4068
ISSN: 1528-0020
0006-4971
Popis: Background: Patients may be unwilling to accept blood products for religious reasons – Jehovah’s Witnesses (JW). Because of its minority, as well as JW patients, physicians have a lot of difficulty and anxiety to treatment. Furthermore, sometimes cancer patients are needed transfusion during operation or chemotherapy. So, we analyze the clinical outcomes of JW cancer patients who had treated for identifying the risk of treatment and transfusion need. Methods: We analyzed 77 cases of histological confirmed cancer patients (JW) from Jan. 2001 to Apr. 2008. Results: Male to female ratio was 1:1.48. Median age of patients was 59 years (range, 8 –83 years). The most common primary site was stomach (20.8%) followed by breast (14.3%), colorectal (11.7%), liver (7.8%), lung (6.5%), and hematologic malignancy (5.2%). At diagnosis, 53 patients (68.8%) were operable early cancer patients. Operation was done in 47 patients (89%). three patients refused operation itself. Change of CBC profile after operation was observed in hemoglobin (Mean ± SD; 12.7 ± 2.1 g/dL to 10.6 ± 2.3 g/dL, P Conclusion: Bloodless cancer treatment was not accompanied with serious complication. A few cases of palliative chemotherapy were needed transfusion, but adequate physician’s assist - dose modification and use of G-CSF and erythropoietin - could make keep the patient’s hope and quality of life.
Databáze: OpenAIRE